Every material Form 8-K Willis Towers Watson filed with the SEC in 2025, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Willis North America, a unit of Willis Towers Watson, completed a public offering of $1 billion in senior notes on December 22, 2025, split between $700 million due 2031 and $300 million due 2036. Net proceeds are approximately $990 million, which the company plans to use mainly for the pending Newfront acquisition and to repay $550 million of 4.400% notes due 2026 if that deal closes.
2031 Notes: $700 million at 4.550%, maturing March 15, 2031
2036 Notes: $300 million at 5.150%, maturing March 15, 2036
Net proceeds approximately $990 million; if Newfront acquisition does not close, proceeds fund repayment of 2026 notes and a special mandatory redemption of the 2036 Notes
Parent Willis Towers Watson and three other subsidiaries fully and unconditionally guarantee the notes
WTW reported third-quarter 2025 results with revenue flat at $2.29 billion from the prior-year quarter, reflecting the TRANZACT sale, while organic revenue grew 5%. Net income was $306 million, compared with a net loss of $1.67 billion a year earlier, which included TRANZACT-related impairment charges. CEO Carl Hess said the company is confident in reaching its full-year financial goals, and the filing reiterates plans for about $1.5 billion in share repurchases in 2025.
Adjusted diluted EPS was $3.07, up 11% from $2.77; reported diluted EPS was $3.11 versus a $(16.44) loss a year earlier.
Adjusted operating margin was 20.4%, up 230 basis points from 18.1%.
WTW repurchased 1,848,098 shares for $600 million during the quarter and expects about $1.5 billion of share repurchases in 2025.
Expects a foreign currency tailwind of about $0.10 to adjusted diluted EPS for full-year 2025.
Willis Towers Watson entered a $1.5 billion revolving credit facility on October 17, 2025, replacing its prior credit agreement from October 2021. The facility matures October 17, 2030 and will refinance existing borrowings, with remaining funds available for working capital, capital expenditures, permitted acquisitions and other corporate purposes.
Willis Towers Watson reported second-quarter 2025 results on July 31, 2025. Reported revenue was flat at $2.26 billion because of the sale of TRANZACT, but organic revenue grew 5%, and both GAAP and adjusted diluted earnings per share rose from the prior-year quarter.
Diluted EPS was $3.32 versus $1.36 a year earlier; adjusted diluted EPS was $2.86 versus $2.39, up 20%.
Revenue was $2.26 billion, flat as reported and up 5% organically; the TRANZACT sale offset growth.
Operating margin was 16.3% versus 9.4%; adjusted operating margin was 18.5% versus 17.0%.
Free cash flow for the six months was $217 million versus $305 million, down $88 million; WTW repurchased 1,614,427 shares for $500 million in the quarter and expects 2025 repurchases of about $1.5 billion.
WTW reported first-quarter 2025 results for the period ended March 31, 2025. Reported revenue fell 5% to $2.2 billion, mainly because of the sale of TRANZACT, while organic revenue grew 5%. Diluted EPS rose 27% to $2.33, but adjusted diluted EPS was flat at $3.13, and free cash flow was negative $86 million.
Revenue was $2,223 million, down 5% from $2,341 million a year earlier; organic revenue rose 5%.
Diluted EPS was $2.33, up 27%; adjusted diluted EPS was $3.13, flat year over year.
Free cash flow was $(86) million versus $(36) million in the prior-year quarter, mainly due to the absence of TRANZACT cash collections.
WTW repurchased 607,221 shares for $200 million in the quarter and expects share repurchases of about $1.5 billion in 2025.
WTW said Non-Executive Chair Paul Thomas informed the board on February 25, 2025 that he will retire and not stand for reelection at the 2025 Annual Meeting of Stockholders. The board selected Paul Reilly, an independent director since October 2022, to become Non-Executive Chair after that meeting, subject to his reelection. The change alters the company's board leadership, and the filing states that Thomas's retirement is not the result of any disagreement with the company.
Paul Thomas informed the board on February 25, 2025 that he will retire and not stand for reelection at the 2025 AGM.
Thomas's retirement is not the result of any disagreement with the company, according to the filing.
Paul Reilly will become Non-Executive Chair effective at the conclusion of the 2025 AGM, subject to his reelection.
Reilly has been an independent director since October 2022 and is currently Executive Chair of Raymond James Financial.
WTW reported fourth-quarter and full-year 2024 results. Revenue rose 5% to $9.9 billion for the year and adjusted diluted EPS rose 17% to $16.93, but the company swung to a GAAP net loss of $88 million, driven mainly by impairment charges of over $1.0 billion tied to the sale of TRANZACT. The filing also gives 2025 expectations, including about $1.5 billion of planned share repurchases.
Full-year 2024 revenue was $9.93 billion, up 5%; organic revenue growth was 5%.
Full-year diluted loss per share was $0.96, versus diluted EPS of $9.95 in 2023, mainly due to impairment charges of over $1.0 billion related to the TRANZACT sale.
Full-year adjusted diluted EPS was $16.93, up 17% from $14.49.
Fourth-quarter diluted EPS was $12.25, up 105%; adjusted diluted EPS was $8.13, up 9%.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Willis Towers Watson filing is on SEC EDGAR ↗. 8-K briefs of other companies →